Search results
Results from the WOW.Com Content Network
Treatment is typically with a catheter either through the urethra or lower abdomen. [1] [3] Other treatments may include medication to decrease the size of the prostate, urethral dilation, a urethral stent, or surgery. [1] Males are more often affected than females. [1] In males over the age of 40 about 6 per 1,000 are affected a year. [1]
Dysuria refers to painful or uncomfortable urination. [ 1 ] [ 2 ] It is one of a constellation of irritative bladder symptoms (also sometimes referred to as lower urinary tract symptoms), which includes nocturia and urinary frequency .
Men with prostatic hypertrophy are advised to sit down whilst urinating. [18] A 2014 meta-analysis found that, for elderly males with LUTS, sitting to urinate meant there was a decrease in post-void residual volume (PVR, ml), increased maximum urinary flow (Qmax, ml/s), which is comparable with pharmacological intervention, and decreased the ...
Signs indicative of urethral syndrome include a history of chronic recurrent urinary tract infections (UTI) in the absence of both conventional bacterial growth and pyuria (more than 5 white blood cells per high power field). [3]
Rates of asymptomatic bacteria in the urine among men over 75 are between 7–10%. [11] 2–10% of pregnant women have asymptomatic bacteria in the urine and higher rates are reported in women who live in some underdeveloped countries. [108] Urinary tract infections may affect 10% of people during childhood. [7]
This process has been called the Stanford protocol or the Wise-Anderson protocol. [57] The American Urological Association in 2014 listed manual physical therapy as a second line treatment. [55] Kegel exercises are not recommended. [55] Treatment may also include a program of "paradoxical relaxation" to prevent chronic tensing of the pelvic ...
Hemorrhagic cystitis or haemorrhagic cystitis is an inflammation of the bladder defined by lower urinary tract symptoms that include dysuria, hematuria, and hemorrhage.The disease can occur as a complication of cyclophosphamide, ifosfamide and radiation therapy.
As of 2019, about 94 million men aged 40 years and older are affected globally. [3] BPH typically begins after the age of 40. [1] The prevalence of clinically diagnosed BPH peaks at 24% in men aged 75–79 years. [3] Based on autopsy studies, half of males aged 50 and over are affected, and this figure climbs to 80% after the age of 80. [3]